Abstract
The impact of n-3 fatty acids (FA) on blood lipoprotein levels has been examined in many studies over the last 15 yr in both animals and humans. Studies in humans first demonstrated the potent triglyceride-lowering effect of n-3 FA, and these were followed up with animal studies to unravel the mechanism of action. This paper reviews the reported effects of n-3 FA on blood lipoproteins in 72 placebo-controlled human trials, at least 2 wk in length and providing 7 or less g of n-3 FA/day. Trials in normolipidemic subjects (triglycerides
| Original language | English (US) |
|---|---|
| Pages (from-to) | 243-252 |
| Number of pages | 10 |
| Journal | Lipids |
| Volume | 31 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1996 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Organic Chemistry
- Cell Biology
- Biochemistry
- Medicine (miscellaneous)
- Biochemistry, Genetics and Molecular Biology(all)
- Food Science
Cite this
n-3 fatty acids and lipoproteins : Comparison of results from human and animal studies. / Harris, William.
In: Lipids, Vol. 31, No. 3, 03.1996, p. 243-252.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - n-3 fatty acids and lipoproteins
T2 - Comparison of results from human and animal studies
AU - Harris, William
PY - 1996/3
Y1 - 1996/3
N2 - The impact of n-3 fatty acids (FA) on blood lipoprotein levels has been examined in many studies over the last 15 yr in both animals and humans. Studies in humans first demonstrated the potent triglyceride-lowering effect of n-3 FA, and these were followed up with animal studies to unravel the mechanism of action. This paper reviews the reported effects of n-3 FA on blood lipoproteins in 72 placebo-controlled human trials, at least 2 wk in length and providing 7 or less g of n-3 FA/day. Trials in normolipidemic subjects (triglycerides
AB - The impact of n-3 fatty acids (FA) on blood lipoprotein levels has been examined in many studies over the last 15 yr in both animals and humans. Studies in humans first demonstrated the potent triglyceride-lowering effect of n-3 FA, and these were followed up with animal studies to unravel the mechanism of action. This paper reviews the reported effects of n-3 FA on blood lipoproteins in 72 placebo-controlled human trials, at least 2 wk in length and providing 7 or less g of n-3 FA/day. Trials in normolipidemic subjects (triglycerides
UR - http://www.scopus.com/inward/record.url?scp=0029865509&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029865509&partnerID=8YFLogxK
U2 - 10.1007/BF02529870
DO - 10.1007/BF02529870
M3 - Article
C2 - 8900453
AN - SCOPUS:0029865509
VL - 31
SP - 243
EP - 252
JO - Lipids
JF - Lipids
SN - 0024-4201
IS - 3
ER -